Cargando…
Alvimopan Addition to a Standard Perioperative Recovery Pathway
BACKGROUND AND OBJECTIVES: Alvimopan, a peripherally acting mu-opioid receptor antagonist, decreased time to gastrointestinal recovery and hospital length of stay in open bowel resection patients in Phase 3 trials. However, the benefit in laparoscopic colectomy patients remains unclear. METHODS: A r...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Society of Laparoendoscopic Surgeons
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340958/ https://www.ncbi.nlm.nih.gov/pubmed/22643504 http://dx.doi.org/10.4293/108680811X13176785204076 |